Source: HIT Consultant Media

DLS: PathAI Partners to Deploy First AI-Powered Biospecimen Solutions

What You Should Know: - PathAI, a leading provider of AI-powered technology for pathology, today announced a strategic partnership with Discovery Life Sciences, a leading biospecimens and specialty lab testing company, to offer Discovery's customers enhanced, AI-enabled digital and quantitative insights from biospecimens to better inform drug and diagnostic development. - This collaboration marks a milestone as the ... Read More

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Greg Herrema's photo - CEO of DLS

CEO

Greg Herrema

CEO Approval Rating

83/100

Read more